Admission to Official List

Imagion Biosystems Limited was admitted to the Official List of ASX today. View the ASX market release: Imagion Biosystems Limited Admission to Official List.


Long Term Incentive Plan

The Long Term Incentive Performance Rights Plan is a long term incentive aimed at creating a stronger link between eimployee performance and reward and…


Securities Trading Policy

Imagion Biosystems Limited (Company) is committed to ensuring that public confidence is maintained in the Company, its people and the trading of its…


Senior Scientific Financial Statements 2015 and 2014

View Financial Statements for Senior Scientific LLC as of December 31, 2015 and 2014 and for the years then ended.


Company Overview Presentation

click image to download pdf file Here are the principal "slide deck" visuals used to introduce Imagion Biosystems to investors prior to the company's initial…


Pre-IPO Investor Conference Call

On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on…


HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference

This year's Tech Connect World Innovation Conference featured the poster "Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors…


Magnetic Relaxometry at the 2017 AACR Meeting

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Magnetic Relaxometry at AACR 2017

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Improving Detection Sensitivity

Scientists at Imagion Biosystems, along with our collaborators, continue to push back the boundaries of detection limits in our quest to improve on the early…